:format(webp))
Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Healthcare professionals should ensure patients understand that whilst tirzepatide does not cause blood clots, their underlying conditions may place them at risk
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Try these prevention habits: Add water before you feel thirsty
The honest answer is that decades-long human data do not yet exist for tirzepatide specifically
Mistake 5: Packing only enough for the exact trip Flights get delayed
